Physician profile
John C Balbas
NPI 1730201682
$4,687.77
in general payments reported to CMS, 2019-2025
19 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,476 · 2020: $392 · 2021: $280 · 2022: $331 · 2023: $1,300 · 2024: $547 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800 · Entertainment: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
| Entertainment | $112.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,255.62 | 2019-2024 | |
| Exactech, INC. | $800.00 | 2023 | |
| Sanofi-Aventis U.S. LLC | $523.29 | 2019-2023 | |
| Pacira Therapeutics, INC. | $466.05 | 2019-2021 | |
| Aesculap Biologics, LLC | $369.73 | 2019-2023 | Novocart 3d |
| Stryker Corporation | $234.91 | 2020-2025 | Mako, Tornier Perform Reversed Glenoid, Gamma |
| P Bar Medical LLC | $157.12 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $156.68 | 2021-2025 | Zilretta, Iovera, Exparel |
| Linvatec Corporation | $149.15 | 2024 | Biobrace 23mm |
| Bioventus LLC | $143.86 | 2019-2024 | Durolane |
| Bodycad USA Corp | $112.29 | 2024 | Fine Osteotomy |
| Depuy Synthes Sales INC. | $82.21 | 2019-2025 | Na, Lcp |
| Horizon Therapeutics Plc | $62.18 | 2019-2022 | |
| Smith+Nephew, INC. | $54.72 | 2025 | Collagenase Santyl |
| Vertex Pharmaceuticals Incorporated | $50.25 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $25.90 | 2019 | |
| Avanos Medical | $18.31 | 2019 | |
| Endo Pharmaceuticals INC. | $13.83 | 2019 | |
| Zyla Life Sciences, INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Balbas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.